FTO and acute myeloid leukemia: Another translational advance was the development of two small-molecule FTO inhibitors, FB23 and FB23-2, which blocked its demethylase activity and suppressed AML cell growth while promoting differentiation and apoptosis in vitro and in vivo [51].